Two-Year Real-World Effectiveness of Semaglutide in Patients with Obesity or Overweight

Related

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026

• Semaglutide may protect kidneys by reducing vascular resistance

  Nature Medicine · 4 Oct 2026

  

• A triple-target drug cut body weight by up to 19.7% in a trial

  Cell Metabolism · 8 Oct 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet · 4 Oct 2026